Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Depreciation & Amortization (CF): 2022-2023

Historic Depreciation & Amortization (CF) for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $77,000.

  • Lexeo Therapeutics' Depreciation & Amortization (CF) rose 32.76% to $77,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $271,000, marking a year-over-year change of. This contributed to the annual value of $304,000 for FY2024, which is 12.18% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' Depreciation & Amortization (CF) stood at $77,000, which was down 1.28% from $78,000 recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Depreciation & Amortization (CF) registered a high of $78,000 during Q3 2023, and its lowest value of $57,000 during Q1 2023.
  • For the 2-year period, Lexeo Therapeutics' Depreciation & Amortization (CF) averaged around $65,800, with its median value being $59,000 (2023).
  • Data for Lexeo Therapeutics' Depreciation & Amortization (CF) shows a peak YoY soared of 32.76% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Lexeo Therapeutics' Depreciation & Amortization (CF) stood at $58,000 in 2022, then soared by 32.76% to $77,000 in 2023.
  • Its Depreciation & Amortization (CF) was $77,000 in Q4 2023, compared to $78,000 in Q3 2023 and $59,000 in Q2 2023.